Management of lobular neoplasia diagnosed by core needle biopsy: Study of 52 biopsies with follow-up surgical excision

Breast

Volumn 16, Issue 5, 2007, Pages 533-539

  Lavoué, Vincent ^a,b   Graesslin, Olivier ^a   Classe, Jean Marc ^c   Fondrinier, Eric ^d   Angibeau, Hélène ^e   Levêque, Jean ^b  

^a HÔPITAL TENON   (France)

^b Eugène Marquis Comprehensive Cancer Center   (France)

^c ICO Institut de Cancérologie de l Ouest   (France)

^d Paul Papin Cancer Center   (France)

^e University of Poitiers   (France)

Author keywords

Breast cancer; Core needle biopsy; Lobular neoplasia; Surgical excision

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST CARCINOMA; BREAST SURGERY; CANCER SCREENING; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LOBULAR NEOPLASIA; MAJOR CLINICAL STUDY; MAMMOGRAPHY; NEEDLE BIOPSY; PAGET NIPPLE DISEASE; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

EID: 34848909051     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.breast.2007.04.005     Document Type: Article

References (50)

1. Tavassoli FA, Boeckler W, Lakhani SR. Lobular neoplasia. World Health Organization classification of tumours. Pathology and genetics of the breast and female genital organs. Lyon; 2003.
2. Haagensen C.D., Lane N., Lattes R., and Bodian C. Lobular neoplasia (so-called lobular carcinoma in situ) of the breast. Cancer 42 2 (1978) 737-769
3. Li C.I., Anderson B.O., Daling J.R., and Moe R.E. Changing incidence of lobular carcinoma in situ of the breast. Breast Cancer Res Treat 75 3 (2002) 259-268
4. Li C.I., Daling J.R., and Malone K.E. Age-specific incidence rates of in situ breast carcinomas by histologic type, 1980 to 2001. Cancer Epidemiol Biomarkers Prev 14 4 (2005) 1008-1011
5. Pope Jr. T.L., Fechner R.E., Wilhelm M.C., Wanebo H.J., and de Paredes E.S. Lobular carcinoma in situ of the breast: mammographic features. Radiology 168 1 (1988) 63-66
6. Frykberg E.R. Lobular carcinoma in situ of the breast. Breast J 5 5 (1999) 296-303
7. Urban J.A. Bilaterality of cancer of the breast. Biopsy of the opposite breast. Cancer 20 11 (1967) 1867-1870
8. Rosen P.P., Senie R., Schottenfeld D., and Ashikari R. Noninvasive breast carcinoma: frequency of unsuspected invasion and implications for treatment. Ann Surg 189 3 (1979) 377-382
9. Wheeler J.E., Enterline H.T., Roseman J.M., Tomasulo J.P., McIlvaine C.H., Fitts W.T., et al. Lobular carcinoma in situ of the breast Long-term followup. Cancer 34 3 (1974) 554-563
10. Page D.L., Schuyler P.A., Dupont W.D., Jensen R.A., Plummer Jr. W.D., and Simpson J.F. Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study. Lancet 361 9352 (2003) 125-129
11. Andersen J.A. Lobular carcinoma in situ. A long-term follow-up in 52 cases. Acta Pathol Microbiol Scand [A] 82 4 (1974) 519-533
12. Page D.L., Dupont W.D., Rogers L.W., and Rados M.S. Atypical hyperplastic lesions of the female breast. A long-term follow-up study. Cancer 55 11 (1985) 2698-2708
13. Page D.L., Kidd Jr. T.E., Dupont W.D., Simpson J.F., and Rogers L.W. Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease. Hum Pathol 22 12 (1991) 1232-1239
14. Chuba P.J., Hamre M.R., Yap J., Severson R.K., Lucas D., Shamsa F., et al. Bilateral risk for subsequent breast cancer after lobular carcinoma-in-situ: analysis of surveillance, epidemiology, and end results data. J Clin Oncol 23 24 (2005) 5534-5541
15. Andersen J.A. Lobular carcinoma in situ of the breast. An approach to rational treatment. Cancer 39 6 (1977) 2597-2602
16. Fisher B., Costantino J.P., Wickerham D.L., Cecchini R.S., Cronin W.M., Robidoux A., et al. Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J Natl Cancer Inst 97 22 (2005) 1652-1662
17. Vogel V.G., Costantino J.P., Wickerham D.L., Cronin W.M., Cecchini R.S., Atkins J.N., et al. Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. J Am Med Assoc 295 23 (2006) 2727-2741
18. Radiology ACo. Breast imaging and data reporting system (BIRADS). 3rd ed. Reston, VA; 1998.
19. Simpson P.T., Reis-Filho J.S., Gale T., and Lakhani S.R. Molecular evolution of breast cancer. J Pathol 205 2 (2005) 248-254
20. Foster M.C., Helvie M.A., Gregory N.E., Rebner M., Nees A.V., and Paramagul C. Lobular carcinoma in situ or atypical lobular hyperplasia at core-needle biopsy: is excisional biopsy necessary?. Radiology 231 3 (2004) 813-819
21. Berg W.A., Mrose H.E., and Ioffe O.B. Atypical lobular hyperplasia or lobular carcinoma in situ at core-needle breast biopsy. Radiology 218 2 (2001) 503-509
22. Sonnenfeld M.R., Frenna T.H., Weidner N., and Meyer J.E. Lobular carcinoma in situ: mammographic-pathologic correlation of results of needle-directed biopsy. Radiology 181 2 (1991) 363-367
23. Georgian-Smith D., and Lawton T.J. Calcifications of lobular carcinoma in situ of the breast: radiologic-pathologic correlation. AJR Am J Roentgenol 176 5 (2001) 1255-1259
24. Crisi G.M., and Ricci Jr. A. Follow-up surgical excision is indicated when breast core needle biopsies show atypical lobular hyperplasia or lobular carcinoma in situ. Am J Surg Pathol 29 12 (2005) 1684-1685
25. Dmytrasz K., Tartter P.I., Mizrachy H., Chinitz L., Rosenbaum Smith S., and Estabrook A. The significance of atypical lobular hyperplasia at percutaneous breast biopsy. Breast J 9 1 (2003) 10-12
26. Elsheikh T.M., and Silverman J.F. Follow-up surgical excision is indicated when breast core needle biopsies show atypical lobular hyperplasia or lobular carcinoma in situ: a correlative study of 33 patients with review of the literature. Am J Surg Pathol 29 4 (2005) 534-543
27. Irfan K., and Brem R.F. Surgical and mammographic follow-up of papillary lesions and atypical lobular hyperplasia diagnosed with stereotactic vacuum-assisted biopsy. Breast J 8 4 (2002) 230-233
28. O'Driscoll D., Britton P., Bobrow L., Wishart G.C., Sinnatamby R., and Warren R. Lobular carcinoma in situ on core biopsy-what is the clinical significance?. Clin Radiol 56 3 (2001) 216-220
29. Philpotts L.E., Shaheen N.A., Jain K.S., Carter D., and Lee C.H. Uncommon high-risk lesions of the breast diagnosed at stereotactic core-needle biopsy: clinical importance. Radiology 216 3 (2000) 831-837
30. Arpino G., Allred D.C., Mohsin S.K., Weiss H.L., Conrow D., and Elledge R.M. Lobular neoplasia on core-needle biopsy-clinical significance. Cancer 101 2 (2004) 242-250
31. Liberman L., Sama M., Susnik B., Rosen P.P., LaTrenta L.R., Morris E.A., et al. Lobular carcinoma in situ at percutaneous breast biopsy: surgical biopsy findings. AJR Am J Roentgenol 173 2 (1999) 291-299
32. Mahoney M.C., Robinson-Smith T.M., and Shaugnessy E.A. Lobular neoplasia at 11-Gauge vacuum-assisted stereotactic biopsy: correlation with surgical excisional biopsy and mammographic follow-up. AJR 187 10 (2006) 949-954
33. Middleton L.P., Grant S., Stephens T., Stelling C.B., Sneige N., and Sahin A.A. Lobular carcinoma in situ diagnosed by core needle biopsy: when should it be excised?. Mod Pathol 16 2 (2003) 120-129
34. McLaren B.K., Schuyler P.A., Sanders M.E., Jensen R.A., Simpson J.F., Dupont W.D., et al. Excellent survival, cancer type, and Nottingham grade after atypical lobular hyperplasia on initial breast biopsy. Cancer 107 6 (2006) 1227-1233
35. Cohen M.A. Cancer upgrades at excisional biopsy after diagnosis of atypical lobular hyperplasia or lobular carcinoma in situ at core-needle biopsy: some reasons why. Radiology 231 3 (2004) 617-621
36. Sneige N., Wang J., Baker B.A., Krishnamurthy S., and Middleton L.P. Clinical, histopathologic, and biologic features of pleomorphic lobular (ductal-lobular) carcinoma in situ of the breast: a report of 24 cases. Mod Pathol 15 10 (2002) 1044-1050
37. Bratthauer G.L., and Tavassoli F.A. Lobular intraepithelial neoplasia: previously unexplored aspects assessed in 775 cases and their clinical implications. Virchows Arch 440 2 (2002) 134-138
38. Reis-Filho J.S., Simpson P.T., Jones C., Steele D., Mackay A., Iravani M., et al. Pleomorphic lobular carcinoma of the breast: role of comprehensive molecular pathology in characterization of an entity. J Pathol 207 1 (2005) 1-13
39. Lerwill M.F. Current practical applications of diagnostic immunohistochemistry in breast pathology. Am J Surg Pathol 28 8 (2004) 1076-1091
40. Lerwill M.F. The evolution of lobular neoplasia. Adv Anat Pathol 13 4 (2006) 157-165
41. Fadare O., Dadmanesh F., Alvarado-Cabrero I., Snyder R., Mitchell J.S., Tot T., et al. Lobular intraepithelial neoplasia [lobular carcinoma in situ] with comedo-type necrosis. A clinicopathologic study of 18 cases. Am J Surg Pathol 30 11 (2006) 1445-1453
42. Pacelli A., Rhodes D.J., Amrani K.K., and Reynolds C. Outcome of atypical lobular hyperplasia and lobular carcinoma in situ diagnosed by core needle biopsy: clinical and surgical follow-up of 30 cases. Am J Clin Pathol 116 (2001) 591-592
43. Shin S.J., and Rosen P.P. Excisional biopsy should be performed if lobular carcinoma in situ is seen on needle core biopsy. Arch Pathol Lab Med 126 6 (2002) 697-701
44. Jackman R.J., Birdwell R.L., and Ikeda D.M. Atypical ductal hyperplasia: can some lesions be defined as probably benign after stereotactic 11-gauge vacuum-assisted biopsy, eliminating the recommendation for surgical excision?. Radiology 224 2 (2002) 548-554
45. Lakhani S.R., Audretsch W., Cleton-Jensen A.M., Cutuli B., Ellis I., Eusebi V., et al. The management of lobular carcinoma in situ (LCIS). Is LCIS the same as ductal carcinoma in situ (DCIS)?. Eur J Cancer 42 14 (2006) 2205-2211
46. Lechner M., Jackmen R., Brem R., Evans W., Parker S., and Smid A. Lobular carcinoma in situ and atypical lobular hyperplasia at percutaneous biopsy with surgical correlation: a multi-institutional study. Radiology 213P (1999) 106
47. Bauer V.P., Ditkoff B.A., Schnabel F., Brenin D., El-Tamer M., and Smith S. The management of lobular neoplasia identified on percutaneous core breast biopsy. Breast J 9 1 (2003) 4-9
48. Yeh I.T., Dimitrov D., Otto P., Miller A.R., Kahlenberg M.S., and Cruz A. Pathologic review of atypical hyperplasia identified by image-guided breast needle core biopsy. Correlation with excision specimen. Arch Pathol Lab Med 127 1 (2003) 49-54
49. Meloni G.B., Becchere M.P., Soro D., Feo C.F., Profili S., Dettori G., et al. Percutaneous vacuum-assisted core breast biopsy with upright stereotactic equipment. Indications, limitations and results. Acta Radiol 43 6 (2002) 575-578
50. Renshaw A.A., Cartagena N., Derhagopian R.P., and Gould E.W. Lobular neoplasia in breast core needle biopsy specimens is not associated with an increased risk of ductal carcinoma in situ or invasive carcinoma. Am J Clin Pathol 117 5 (2002) 797-799